Your session is about to expire
← Back to Search
Procedure
Photodynamic Therapy for Skin Cancer
Phase 2
Waitlist Available
Research Sponsored by Laser and Skin Surgery Center of New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Tumor size ≤ 2 cm in diameter
Biopsy-proven basal cell carcinoma on the trunk or extremities
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial uses a drug that becomes active when exposed to light to kill cancer cells. It is testing to see if this is an effective treatment against skin cancer and what side effects there may be.
Who is the study for?
This trial is for mentally competent adults with a confirmed diagnosis of basal cell carcinoma on their trunk or limbs, and the tumor must be 2 cm in diameter or smaller. Participants should not have infections, history of severe scarring, light-triggered conditions, be taking blood thinners (excluding aspirin), immunosuppressants, antioxidants, or have had certain skin treatments and procedures within specific time frames.Check my eligibility
What is being tested?
The study is testing photodynamic therapy using aminolevulinic acid to treat non-melanoma skin cancer. The drug activates under particular light conditions to kill tumor cells. This phase II trial aims to evaluate the effectiveness and side effects of this treatment approach.See study design
What are the potential side effects?
Potential side effects may include reactions at the site where the drug is applied such as redness, swelling, and discomfort due to sensitivity to light since the treatment involves activating drugs with light exposure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My tumor is 2 cm or smaller in size.
Select...
I have a confirmed basal cell carcinoma on my trunk or limbs.
Select...
I am mentally capable of making my own decisions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Efficacy
Safety
Find a Location
Who is running the clinical trial?
Laser and Skin Surgery Center of New YorkLead Sponsor
3 Previous Clinical Trials
1,331 Total Patients Enrolled
Diana SantanelloLaser and Skin Surgery Center of New York
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I currently have an infection.I haven't taken oral retinoids or photosensitizing drugs in the last 24 months.You have had keloids in the past.You have a history of skin reactions to sunlight or certain chemicals.I have had radiation therapy to my body or limbs.My tumor is 2 cm or smaller in size.I have a confirmed basal cell carcinoma on my trunk or limbs.I am mentally capable of making my own decisions.I am currently taking blood thinners.My immune system is weak.I am currently taking aspirin or antioxidants.I haven't had cosmetic skin treatments like Botox or peels in the last year.I have a blood clotting disorder.I stopped using topical retinoids less than a month ago.You are sensitive to sunlight or have an allergy to it.I have previously been treated with gold therapy.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Could you please outline the risks associated with this treatment plan?
"This is a Phase 2 trial, which means that while there is some safety data, there is no evidence yet of the treatment's efficacy. Our team rates it as a 2."
Answered by AI
Are new patients being accepted into this research project?
"Unfortunately, this study is not currently seeking participants. Although the trial was last updated over 6 years ago, there are 166 other trials that may be a better match for patients looking to get involved in clinical research."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger